ERCC2 and acute myeloid leukemia: Targeted treatment to MDM2 has been shown to rapidly reduce JAK2 V617F allele burden [135]. Among the genes reducing the risk for AML, ERCC2, which is part of the DNA repair and nucleotide excision repair (NER) pathway [136], was also found in the analysis of the present in the Arab population.